tiprankstipranks
Alnylam Pharmaceuticals (ALNY)
NASDAQ:ALNY
US Market
ALNY
Alnylam Pharma
RESEARCH TOOLSreports
Want to see ALNY full AI Analyst Report?

Alnylam Pharma (ALNY) Ratios

1,410 Followers

Alnylam Pharma Ratios

ALNY's free cash flow for Q4 2025 was $0.76. For the 2025 fiscal year, ALNY's free cash flow was decreased by $ and operating cash flow was $0.12. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.13 2.76 2.78 3.08 3.51
Quick Ratio
 3.06 2.71 2.71 2.99 3.34
Cash Ratio
 1.27 1.13 0.81 0.84 1.13
Solvency Ratio
 0.15 0.09 -0.05 -0.10 -0.29
Operating Cash Flow Ratio
 0.53 0.36 >-0.01 0.11 -0.70
Short-Term Operating Cash Flow Coverage
 15.61 0.00 -0.07 0.00 0.00
Net Current Asset Value
$ -126.49M$ -126.49M$ -877.61M$ -1.07B$ -1.01B
Leverage Ratios
Debt-to-Assets Ratio
 0.25 0.26 0.65 0.34 0.37
Debt-to-Equity Ratio
 1.18 1.62 40.89 -5.92 -8.34
Debt-to-Capital Ratio
 0.54 0.62 0.98 1.20 1.14
Long-Term Debt-to-Capital Ratio
 0.53 0.56 0.97 1.28 1.18
Financial Leverage Ratio
 4.77 6.29 63.20 -17.36 -22.41
Debt Service Coverage Ratio
 3.95 2.17 -0.31 -2.19 -5.97
Interest Coverage Ratio
 5.20 1.99 -1.25 -2.33 -5.03
Debt to Market Cap
 0.03 0.02 0.08 0.04 0.04
Interest Debt Per Share
 10.67 11.69 22.60 11.42 12.13
Net Debt to EBITDA
 -0.80 -0.68 -9.94 -1.91 -0.49
Profitability Margins
Gross Profit Margin
58.59%81.77%85.62%83.02%83.73%
EBIT Margin
9.80%13.51%-10.48%-17.08%-93.60%
EBITDA Margin
17.03%15.00%-7.95%-14.12%-89.31%
Operating Profit Margin
17.54%13.51%-7.87%-15.43%-75.68%
Pretax Profit Margin
13.68%8.70%-16.79%-23.71%-108.63%
Net Profit Margin
13.46%8.45%-12.37%-24.08%-109.04%
Continuous Operations Profit Margin
13.46%8.45%-12.37%-24.08%-109.04%
Net Income Per EBT
98.43%97.09%73.71%101.55%100.37%
EBT Per EBIT
77.96%64.43%213.34%153.63%143.55%
Return on Assets (ROA)
6.32%6.32%-6.56%-11.49%-31.90%
Return on Equity (ROE)
90.35%39.76%-414.62%199.53%714.91%
Return on Capital Employed (ROCE)
14.33%14.33%-5.79%-9.86%-28.26%
Return on Invested Capital (ROIC)
13.74%13.74%-4.06%-9.72%-27.84%
Return on Tangible Assets
6.32%6.32%-6.56%-11.49%-31.90%
Earnings Yield
0.79%0.60%-0.93%-1.84%-3.91%
Efficiency Ratios
Receivables Turnover
 4.85 4.78 5.55 5.58 4.36
Payables Turnover
 4.80 5.85 3.66 5.59 1.72
Inventory Turnover
 7.23 8.19 4.12 3.48 1.31
Fixed Asset Turnover
 6.06 5.25 3.24 2.52 1.40
Asset Turnover
 0.84 0.75 0.53 0.48 0.29
Working Capital Turnover Ratio
 1.57 1.58 1.09 0.93 0.51
Cash Conversion Cycle
 58.68 58.63 54.62 104.98 150.46
Days of Sales Outstanding
 76.42 76.42 65.80 65.44 83.72
Days of Inventory Outstanding
 44.47 44.59 88.62 104.82 278.83
Days of Payables Outstanding
 62.21 62.37 99.80 65.28 212.09
Operating Cycle
 120.89 121.00 154.42 170.26 362.55
Cash Flow Ratios
Operating Cash Flow Per Share
 5.36 4.00 -0.07 0.83 -4.45
Free Cash Flow Per Share
 4.83 3.55 -0.33 0.34 -5.04
CapEx Per Share
 0.54 0.45 0.27 0.50 0.59
Free Cash Flow to Operating Cash Flow
 0.90 0.89 5.12 0.40 1.13
Dividend Paid and CapEx Coverage Ratio
 9.96 8.93 -0.24 1.67 -7.51
Capital Expenditure Coverage Ratio
 9.96 8.93 -0.24 1.67 -7.51
Operating Cash Flow Coverage Ratio
 0.56 0.41 >-0.01 0.08 -0.41
Operating Cash Flow to Sales Ratio
 0.17 0.14 >-0.01 0.06 -0.52
Free Cash Flow Yield
1.16%0.89%-0.14%0.18%-2.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 71.25 166.04 -107.99 -54.31 -25.57
Price-to-Sales (P/S) Ratio
 9.63 14.03 13.36 13.08 27.88
Price-to-Book (P/B) Ratio
 38.25 66.01 447.73 -108.36 -182.78
Price-to-Free Cash Flow (P/FCF) Ratio
 64.39 111.94 -705.29 569.99 -47.15
Price-to-Operating Cash Flow Ratio
 57.69 99.40 -3.61K 229.54 -53.43
Price-to-Earnings Growth (PEG) Ratio
 0.03 -0.79 2.84 0.87 -0.88
Price-to-Fair Value
 38.25 66.01 447.73 -108.36 -182.78
Enterprise Value Multiple
 55.98 92.81 -177.89 -94.49 -31.70
Enterprise Value
 39.81B 51.71B 31.81B 24.40B 29.37B
EV to EBITDA
 84.22 92.81 -177.89 -94.49 -31.70
EV to Sales
 10.72 13.92 14.15 13.35 28.31
EV to Free Cash Flow
 85.54 111.12 -747.01 581.74 -47.89
EV to Operating Cash Flow
 75.96 98.68 -3.83K 234.27 -54.27
Tangible Book Value Per Share
 8.09 6.02 0.53 -1.77 -1.30
Shareholders’ Equity Per Share
 8.09 6.02 0.53 -1.77 -1.30
Tax and Other Ratios
Effective Tax Rate
 -0.04 0.03 0.26 -0.02 >-0.01
Revenue Per Share
 32.26 28.35 17.61 14.64 8.53
Net Income Per Share
 4.34 2.39 -2.18 -3.52 -9.30
Tax Burden
 0.97 0.97 0.74 1.02 1.00
Interest Burden
 0.77 0.64 1.60 1.39 1.16
Research & Development to Revenue
 0.36 0.36 0.50 0.55 0.85
SG&A to Revenue
 0.33 0.33 0.43 0.44 0.74
Stock-Based Compensation to Revenue
 0.07 0.09 0.12 0.12 0.22
Income Quality
 1.67 1.67 0.03 -0.24 0.48
Currency in USD